GGrantIndex
Sort

40,608 grants matching prostate cancer

Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS

$735,451
Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Project 3: Integrative and Functional Genomics of Aggressive Prostate Cancer in African American Men

$735,449
John David Carpten · University Of Southern California · U19 · FY2021 · CA

LARGE SCALE GENE DISCOVERY--HUMAN PROSTATE CANCER

$735,404
Origene Technologies, Inc. · R44 · FY2000 · CA

Administrative Core

$735,082
Shafiq A Khan · Clark Atlanta University · U54 · FY2023 · MD

SYNTHETIC LETHALITY AS A TARGETED APPROACH TO ADVANCED PROSTATE CANCER

$735,082
Trustees Of Boston University · · FY2011 · Department of the Army

LOW-MOLECULAR WEIGHT LIGANDS FOR PROSTATE CANCER

$734,696
Beth Israel Deaconess Medical Center · R33 · FY2003 · CA

DESCRIPTION OF MERTK AS A MARKER OF DISEASE AGGRESSIVENESS AND REGULATOR OF PROSTATE CANCER METASTASIS

$734,666
The Johns Hopkins University · · FY2013 · Department of the Army

Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial

$734,554
Saundra Buys · University Of Utah · N01 · FY2009 · CA

PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapy

$734,548
Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapy

$734,548
Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Onco-primary care networking to support TEAM-based care - the ONE TEAM Study

$734,535
Kevin Charles Oeffinger · Duke University · R01 · FY2021 · CA

Enabling Point of Care Screening for Sepsis Using Rapid Single Cell Analysis

$734,141
Ajay Shah · Cytovale, Inc. · R44 · FY2017 · HL

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology

$734,066
Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA

Marshfield Community Clinical Oncology Program

$734,025
Marshfield Clinic Research Foundation · U10 · FY2004 · CA

Western New York Cancer Coalition (WNYC2) Center to Reduce Disparities

$734,017
Willie Underwood · Roswell Park Cancer Institute Corp · U54 · FY2014 · CA

Genetic Aspects Of Viral Oncogenesis In Wild Mouse Species

$733,926
Christine Kozak · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Identification of epigenetic drivers of advanced prostate cancer

$733,909
David Takeda · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Mechanism of epigenetic activation during disease progression

$733,909
David Takeda · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Case-Control Study of Pancreas Cancer Etiologic Factors

$733,890
Harvey A Risch · Yale University · R01 · FY2007 · CA

Enabling Technologies for MRI-Guided Prostate Interventions

$733,890
Clare M Tempany · Brigham And Women'S Hospital · R01 · FY2014 · CA

Preserving Erectile Function by Quantifying the Nerve-Sparing step of the Robotic Prostatectomy

$733,887
Andrew Hung · Cedars-Sinai Medical Center · R01 · FY2025 · CA

CANCER PREVENTION AND CONTROL TRAINING GRANT

$733,877
University Of Arizona · R25 · FY2002 · CA

Men Moving Forward: A Lifestyle Intervention for African American Prostate Cancer Survivors

$733,795
Melinda R Stolley · Medical College Of Wisconsin · R01 · FY2019 · CA

Molecular, Cellular, and Tissue Characterization Unit

$733,794
Joe W. Gray · Oregon Health & Science University · U2C · FY2020 · CA

Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)

$733,721
Jim Hu · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA